Sick leave and disability pension in inflammatory bowel disease: A systematic review

被引:46
作者
Busch, Katharina [1 ]
da Silva, Simone A. [2 ]
Holton, Michelle [3 ]
Rabacow, Fabiana M. [2 ]
Khalili, Named [4 ]
Ludvigsson, Jonas F. [5 ,6 ]
机构
[1] Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, SE-17176 Stockholm, Sweden
[2] Univ Sao Paulo, Dept Prevent Med, Sao Paulo, Brazil
[3] Lorimer Enterprises Inc, Red Deer, AB, Canada
[4] Massachusetts Gen Hosp, Digest Healthcare Ctr, Boston, MA 02114 USA
[5] Orebro Univ Hosp, Dept Pediat, Orebro, Sweden
[6] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17176 Stockholm, Sweden
关键词
Work outcomes; Crohn's disease; Ulcerative colitis; Review; QUALITY-OF-LIFE; SEVERE CROHNS-DISEASE; ACTIVITY IMPAIRMENT QUESTIONNAIRE; PERMANENT WORK DISABILITY; REGIONAL PATIENT GROUP; ULCERATIVE-COLITIS; CERTOLIZUMAB PEGOL; CLINICAL-TRIAL; HEALTH; PRODUCTIVITY;
D O I
10.1016/j.crohns.2014.06.006
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & aims: Inflammatory bowel disease has considerable effects on work-related outcomes and leads to high societal costs due to sick leave and disability pension. The aims of this study were to systematically review evidence on work-related outcomes that are relevant to productivity losses and to evaluate whether medical or surgical interventions have a positive impact on patients work ability. Methods: A systematic literature search in PubMed was conducted in June 2013. Abstracts were screened by two independent reviewers, and full-text articles describing the frequency of work-related outcomes were retrieved. Two independent reviewers extracted data according to the PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses. Findings were organized by study design (non-interventional/interventional). Non-interventional studies were structured according to whether they presented data in comparison to control groups or not and interventional studies were summarized according to type of intervention. Results: This review included 30 non-interventional (15 with comparison groups and 15 without comparison group) and 17 interventional studies (9 surgical and 8 medical). The majority of the studies reported a high burden of work:related outcomes among inflammatory bowel disease patients regardless of the methodology used. While biologic agents showed positive effect on work absenteeism and presenteeism in randomized clinical trials, the impact of surgical interventions needs further evaluation. Conclusions: Inflammatory bowel disease patients experience a high burden in work-related outcomes. Additional data on productivity losses and the long-term impact of interventions is needed to help inform decision-makers about treatment options and their benefits in reducing productivity losses in inflammatory bowel disease patients. (C) 2014 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1362 / 1377
页数:16
相关论文
共 69 条
  • [1] The Self-Reported Health and Productivity Burden of Autoimmune Disorders at a Major Self-Insured Employer
    Allen, Harris
    Bunn, William B., III
    Naim, Ahmad B.
    [J]. JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2012, 54 (09) : 1049 - 1063
  • [2] Permanent work disability in Crohn's disease
    Ananthakrishnan, Ashwin N.
    Weber, Lydia R.
    Knox, Josh F.
    Skaros, Susan
    Emmons, Jeanne
    Lundeen, Sarah
    Issa, Mazen
    Otterson, Mary F.
    Binion, David G.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (01) : 154 - 161
  • [3] [Anonymous], GUT
  • [4] Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study
    Bassi, A
    Dodd, S
    Williamson, P
    Bodger, K
    [J]. GUT, 2004, 53 (10) : 1471 - 1478
  • [5] Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease
    Bernklev, T
    Jahnsen, J
    Henriksen, M
    Lygren, I
    Aadland, E
    Sauar, J
    Schulz, T
    Stray, N
    Vatn, M
    Moum, B
    [J]. INFLAMMATORY BOWEL DISEASES, 2006, 12 (05) : 402 - 412
  • [6] Bernstein CN, 2001, AM J GASTROENTEROL, V96, P2117, DOI 10.1111/j.1572-0241.2001.03946.x
  • [7] PROGNOSIS IN CROHNS-DISEASE - BASED ON RESULTS FROM A REGIONAL PATIENT GROUP FROM THE COUNTY OF COPENHAGEN
    BINDER, V
    HENDRIKSEN, C
    KREINER, S
    [J]. GUT, 1985, 26 (02) : 146 - 150
  • [8] Effect of adalimumab on work productivity and indirect costs in moderate to severe Crohn's disease: A meta-analysis
    Binion, David G.
    Louis, Edouard
    Oldenburg, Bas
    Mulani, Parvez
    Bensimon, Arielle G.
    Yang, Mei
    Chao, Jingdong
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY, 2011, 25 (09): : 492 - 496
  • [9] Cost of illness of Crohn's disease
    Bodger, K
    [J]. PHARMACOECONOMICS, 2002, 20 (10) : 639 - 652
  • [10] The impact of inflammatory bowel disease on labor force participation:: Results of a population sampled case-control study
    Boonen, A
    Dagnelie, PC
    Feleus, A
    Hesselink, MA
    Muris, JW
    Stockbrügger, RW
    Russel, MG
    [J]. INFLAMMATORY BOWEL DISEASES, 2002, 8 (06) : 382 - 389